Table 3 |
|||
|
Immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH) results for HER2 protein expression and gene amplification respectively with amplification (in bold) observed in 3/16 (18.8%) mucinous borderline tumors of the ovary. |
|||
|
ID |
IHC (HER2) |
HER2/CEP 17 Ratio |
IHC/FISH concordance |
|
|
|||
|
VB1 |
0 |
0.9 |
|
|
|
|||
|
VB2 |
0 |
0.8 |
|
|
|
|||
|
VB3 |
0 |
0.8 |
|
|
|
|||
|
VB4 |
1 |
1.2 |
|
|
|
|||
|
VB5 |
0 |
1.2 |
|
|
|
|||
|
VB6 |
0 |
1.0 |
|
|
|
|||
|
J1 |
3 |
3.2 |
|
|
|
|||
|
J2 |
0 |
0.8 |
|
|
|
|||
|
J3 |
0 |
1.2 |
|
|
|
|||
|
J4 |
0 |
1.1 |
|
|
|
|||
|
J5 |
0 |
1.1 |
|
|
|
|||
|
J6 |
0 |
1.2 |
|
|
|
|||
|
J7 |
0 |
2.4 |
Discordant |
|
|
|||
|
J8 |
2 |
3.1 |
|
|
|
|||
|
J9 |
0 |
1.3 |
|
|
|
|||
|
J10 |
0 |
1.3 |
|
|
|
|||
|
McAlpine et al. BMC Cancer 2009 9:433 doi:10.1186/1471-2407-9-433 |
|||
